MENU
KALV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

KalVista Pharmaceuticals (KALV) Ownership - Who owns KalVista Pharmaceuticals?

Profile

Industry
Pharmaceuticals Other
Address
55 Cambridge Parkway
Phone
+1 857 999-0075
Employees
118
Web
https://www.kalvista.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
514.3M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
7.44M
Revenue
N/A
Risk (Beta)
-0.21
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

KALV
Capitalization
514M
P/E Ratio
N/A
Risk (Beta)
-0.21
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
7.44M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
88.6M
P/B Ratio
2.98
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
34K
Current Ratio
5.44
Current Revenue Per Employee
68285.71
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
673M
Shares Outstanding - Current
49.2M
Total Liabilities
17.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-14.694
View a ticker or compare two or three
KALV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
55 Cambridge Parkway
Phone
+1 857 999-0075
Employees
118
Web
https://www.kalvista.com